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MRI-related findings qRT-PCR and immunohistochemi-
cal data were acquired for a second cohort of the animal 
model.
Results The evaluation of the pharmacokinetic parameters 
showed a first rise of the transfer coefficient 7 days post-
lesion and a maximum 42 days after operation. The analy-
sis of the complementary data showed a connection of the 
first rise to microvessel proliferation while the maximum 
value was linked to bone remodeling.
Conclusion The pharmacokinetic analysis of DCE-MRI 
provides information on a proliferation of microvessels 
during the healing process as a sign for bone bridge forma-
tion. Thereby, DCE-MRI could identify details, which up 
to now required analyses of highly invasive methods.
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Abbreviations
Ktrans  Transfer coefficient
ve  Extravascular extracellular volume
AIF  Arterial input function
CA  Contrast agent
DCE  Dynamic contrast enhanced
FA  Flip angle
FLASH  Fast low angle shot
FOV  Field of view
Hif1a  Hypoxia-inducible factor 1a
PD  Proton density
RARE  Rapid acquisition with relaxation enhancement
RNA  Ribonucleic acid
RR(M)  Reference region (model)
SNR  Signal-to-noise ratio
TOI  Tissue of interest
VEGFa  Vascular endothelial growth factor a
Abstract 
Objectives Bone bridge formation occurs after physeal 
lesions and can lead to growth arrest if not reversed. Pre-
vious investigations on the underlying mechanisms of this 
formation used histological methods. Therefore, this study 
aimed to apply a minimally invasive method using dynamic 
contrast-enhanced MRI (DCE-MRI).
Materials and methods Changes in functional parameters 
related to the microvessel system were assessed in a lon-
gitudinal study of a cohort of an animal model applying 
a reference region model. The development of morphol-
ogy of the injured physis was investigated with 3D high-
resolution MRI. To acquire complementary information for 
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Introduction
Premature physeal bone bridge formation can be induced 
by a variety of physeal insults including trauma, infec-
tion, radiation, ischemia, thermal injury, Blount disease, 
steroid use, as well as, iatrogenic and unknown etiologies 
[1]. Trauma in general including iatrogenic trauma from 
metal implantation is considered as the leading cause for 
formation of a physeal bone bridge [2, 3]. Bone bridges 
may be reversible when they are small, but can also trigger 
full or partial premature physeal closure due to incomplete 
decomposition and therefore may lead to full or partial 
growth arrest causing bone length discrepancy, axis devia-
tion or joint deformity [4–7]. Clinically, they are detected 
by X-ray examinations, which are either routinely con-
ducted to document fracture healing or initiated in patients 
with posttraumatic bone length alterations or deformities. 
MRI is then used to document the full size of the bridge 
and help in defining further management [1, 4, 8, 9].
A severe physeal bone bridge alters normal longitudi-
nal bone growth and requires either surgical resection and 
filling up the lesion with autologous fat tissue as remedial 
measure or it is managed by contralateral epiphysiodesis 
or corrective osteotomy [1, 5, 6, 9]. Furthermore, stem cell 
therapy [10] and autogenous cultured physeal chondrocyte 
transplantation [11] have been recently investigated experi-
mentally as novel therapeutic option. In contrast, minor 
bone bridges usually remain concealed and disappear dur-
ing further growth, without impairing normal longitudi-
nal growth [6, 7, 12]. Physeal bone bridge formation has 
been documented histologically [13–18] and by MRI [15, 
16, 18] in various experimental animal models. Vasculari-
zation of the physeal lesion has been reported to precede 
physeal bone bridge formation [15, 19]. Along with invad-
ing vessels from surrounding epiphyseal and metaphyseal 
bone, mesenchymal osteoprogenitor cells emerge into the 
physeal lesion site and are attributed to deposit bone which 
eventually leads to bone bridge formation [15, 19]. The 
hypothesis that increased blood supply at the injury site is 
connected to the creation of physeal bone bridges as blood 
vessels and vascular invasion are fundamental for the devel-
opment of bone tissue was further recently supported by the 
detection of increased angiogenic factor expression within 
the physeal injury site prior to bone bridge development 
[13, 20]. However, the underlying pathomechanism induc-
ing angiogenesis followed by formation of a physeal bone 
bridge remains unexplored. The detection of an increase 
in blood supply in a physeal lesion could therefore allow 
an early identification of bone bridge formation and while 
the determination of angiogenic expression factors requires 
tissue samples, magnetic resonance imaging is potentially 
capable of providing this information non-invasively.
Dynamic contrast enhanced MRI (DCE-MRI) is sensi-
tive to functional parameters of the microvessel system. 
It is therefore a tool to characterize angiogenesis and 
microvasculature and is widely used for the analysis of 
tumors [21–23]. The identification of pharmacokinetic 
parameters should therefore allow following the time 
course of microvessel-related functional changes during 
tissue remodeling on an injured physis.
Typical models for the identification of pharmacoki-
netic parameters  [24] require information on the time 
course of tissue contrast agent (CA) concentration and on 
the CA concentration within a feeding artery—the arte-
rial input function (AIF). The simultaneous acquisition 
of both characteristics, i.e. the coverage of the AIF and, 
in this case, the physeal lesion in the same field of view 
(FOV), is very challenging and determines the limits for 
signal-to-noise ratio (SNR), contrast behavior and tempo-
ral or spatial resolution  [25–27].
For investigations where no adequate arterial input 
function is available in the field of view population-
based averaged AIFs [28–30] or model-based arterial 
input functions  [31] can be applied to avoid a decrease 
in SNR or temporal resolution by modifying the FOV. 
A drawback of these methods is, however, that inter-
individual variations between subjects or variations of 
the AIF due to manual CA administration cannot be 
covered. A different approach is to determine the CA 
dynamics of a reference tissue with known pharmacoki-
netic behaviour within the field of view. These dynamic 
data can then be used to apply a reference region model 
(RRM) which allows for the quantification of the phar-
macokinetic parameters of a tissue of interest without 
the direct measurement of or assumptions on the AIF 
[32, 33].
The aim of this study was to investigate pharma-
cokinetic parameters of the microvessel system of a 
physeal lesion in correlation to bone bridge formation. 
These parameters are typically increased in tissues with 
enhanced metabolism and related to permeability surface 
product, blood flow and also blood volume. The investi-
gation of these parameters should support the hypothesis 
that changes of the microvessel system are basic mecha-
nisms associated with bone bridge formation and can 
provide quantitative measures for an early identification 
of this development.
The investigation of physeal lesions in a rat model using 
DCE-MRI required a very high spatial resolution and the 
application of a reference region model. As a complemen-
tary independent measure the results of the MRI analy-
ses were compared to histologic findings and expression 
rates of genes related to vascular growth and oxygenation 
provided by quantitative real-time reverse transcription 
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polymerase chain reaction data (qRT-PCR), which were 
acquired for a second cohort of animals.
Materials and methods
Animals
All animal experiments were conducted under animal ethi-
cal respect and were authorized by the Austrian Ministry of 
Science and Research. Seventy-seven male Sprague–Daw-
ley rats with a weight of approximately 100 g and an age 
of one month were subjected to unilateral physeal lesion 
in general anesthesia using a standardized drill procedure 
[13, 14, 17, 34]. A longitudinal transepiphyseal lesion of 
1.2 mm diameter was drilled through the proximal tibial 
physis, advanced from proximal by a median incision of 
the patella tendon.
For qRT-PCR analyses six animals were euthanized on 
days 0, 1, 3, 7, 14, 28 and 82 post-operation for sample dis-
section. For histological investigations five animals were 
sacrificed on days 1, 3, 7, 14, 28, 42 and 82; for the five 
animals designated for euthanasia on day 82 MR measure-
ments were performed under anesthesia on the same seven 
time-points.
The investigation time-points were set in short intervals 
during the first month post-injury in order to closely fol-
low bone bridge formation and changes in the microvessel 
system. The long-term time-points of 42 and 82 days were 
determined to follow further growth, physeal remodeling 
and to detect a potential disappearance of the bone bridge.
MR measurements
Magnetic resonance imaging of the morphology and 
DCE-MRI were performed on a clinical 3 T scanner with 
38 mT/m gradient strength (Tim Trio, Siemens AG, Erlan-
gen, Germany). For enhanced image quality, especially 
suited surface received coils with a diameter of 18 mm 
(Rapid Biomedical, Rimpar, Germany) were used. Using 
an arrangement as shown in Fig. 1 a minimum distance to 
the rat knees and thereby a maximized SNR could be main-
tained for the complete duration of the study. Animals were 
placed in prone position with their knees in the center of 
the coils. This arrangement was positioned in a semicircu-
lar animal bed (Rapid Biomedical) providing a stable and 
reproducible assembly. As mentioned above, the measure-
ments were performed on days 1, 3, 7, 14, 28, 42 and 82.
Morphological changes of the investigated area were 
imaged with a high-resolution 3D FLASH sequence 
(TE = 7 ms, TR = 100 ms, FA = 15, scanning matrix 
256 × 256, FOV = 50 mm, THK = 0.72 mm) and cor-
onal slice orientation related to the scanner’s refer-
ence system. Image quality was documented calculating 
SNR = µsignal/σcorr, in which µsignal is the average image 
intensity in a region of interest and σcorr is the standard 
deviation of a background region corrected for Rayleigh 
distribution. The corrected standard deviation is calculated 
σcorr = σRayleigh/0.655 with σRayleigh being the standard 
Fig. 1  Arrangement of the 
surface coils for all MR meas-
urements. Left: bottom view, 
right: arrangement of coils in 
the animal bed
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deviation measured in the image background region. 
Regions of interest for SNR determination were skeletal 
muscle and the physis.
The scans for DCE-MRI analysis comprised a single PD-
weighted 3D FLASH reference sequence (TE = 2.95 ms, 
TR = 100 ms, FA = 5) scan and a T1-weighted dynamic 3D 
FLASH sequence (TE = 2.95 ms, TR = 8.09 ms, FA = 30) 
with a temporal resolution of Δt = 13.32 s. This combi-
nation follows the basic idea of the approach proposed by 
Hittmair et al. for 2D FLASH acquisitions [35]. Postopera-
tively a double-dose injection (0.2 mmol/kg) of Gadovist 
(Schering AG, Berlin, Germany) was manually admin-
istered intravenously in the tail vein for DCE-MRI. The 
administration started after the acquisition of three base-
line images for the calculation of pre-contrast longitudinal 
relaxation time T1; the entire protocol comprised 40 acqui-
sitions. All scans for DCE-MRI were acquired in coronal 
orientation and featured a 205 × 256 matrix, a field of view 
of 50 mm and a slice thickness of 0.72 mm.
Reference region model
Due to the absence of an adequate vessel providing an arte-
rial input function in the FOV, blood supply related prop-
erties of the lesioned tissue were investigated by applying 
a reference region model  [33] to the acquired DCE data. 
Maps of the longitudinal relaxation time T1 were generated 
as proposed by Merwa et al. [36] according to Eq. (1)
where S is the signal intensity in the image, θ is the flip 
angle and the subscripts REF and DCE denote reference 
scan and dynamic scan, respectively. According to Yan-
keelov et al. [33] and using the notation suggested by Tofts 
et al. [24], the relaxation rate R1 ≡ 1/T1 of a tissue of inter-
est (TOI) is related to the reference region by
In Eq. (2) K trans is the transfer coefficient, ve is 
the extravascular extracellular volume, R equals 
K
trans,TOI/K trans,RR, R10 is the native relaxation rate in 
absence of a contrast agent and TOI and RR denote the tis-
sue of interest and the reference region, respectively.
The reference region for all investigations was skeletal 
muscle close to the area of the physeal lesion, i.e. the tis-
sue of interest, and the pharmacokinetic parameters of 






SREF sin(θDCE)−SDCE(t) sin(θREF) cos(θDCE)
) ,
(2)
R1,TOI(T) = R · (R1,RR(t) − R10,RR)+ R · [K
trans,RR/ve,RR






(−K trans,TOI/ve,TOI)(T−t)dt + R10,TOI.
ve,RR = 0.08  [37–39]. For all measurements, the subjects’ 
knees were located as close as possible to the center of the 
3D slab to avoid different biases for the estimates of R1 for 
RR and TOI due to B1 inhomogeneities. The least mean 
squares routine for the parameter identification of K trans,TOI 
and ve,TOI was realized in Matlab (TheMathWorks Inc., 
Natick, MA, USA).
Histology
To obtain information on vascularisation complementary to 
the results of the analysis of the pharmacokinetic param-
eters, immunohistochemical analysis was performed for 
samples of the proximal epiphysis, physis and metaphysis 
of the tibial bone on the same days for a second cohort of 
animals.
Histological samples were fixed in methanol (100%) for 
24 h and subsequently subjected to decalcification using 
Ethylenediamine Tetraacetic Acid (pH 7.0) for two weeks. 
Following a further fixation step in methanol (100%) for 
12 h the samples were washed in PBS-sucrose 5% solution, 
covered with tissue freezing medium (Tissue Tek O.C.T. 
Compound, Sakura Finetek Europe B.V., The Netherlands) 
and cut into slices of 7 mm thickness.
To visualize angiogenesis of the physeal defect a colla-
gen IV staining was used, as collagen IV represents a pro-
tein of the basal membrane of vessels, staining vasculature 
in a red/brown colour.
Quantitative real‑time reverse transcription polymerase 
chain reaction
Additionally to MR measurements and histological analy-
sis, factors related to vascular growth and oxygenation 
were determined using quantitative real-time reverse tran-
scription polymerase chain reaction analyses. The qRT-
PCR analyses were performed for vascular endothelial 
growth factor a (VEGFa), which is a key parameter of angi-
ogenesis [40] and hypoxia-inducible factor 1a (Hif1a) as a 
reporter for hypoxia.
For the analysis, physeal samples were dissected from 
the epiphysis and metaphysis under the microscope before 
storage in liquid nitrogen. The samples were homogenized 
using a tissue homogenizer and RNA was extracted using 
TRIZOL (Gibco BRL). Total RNA samples (2.5 mg) were 
reverse transcribed at 42 °C for 15 min using random hex-
amer priming. To establish quantitative expression profiles 
for VEGFa and Hif1a, commercially available, pre-opti-
mized real time-PCR assays (Assay On Demand, Applied 
Biosystems) were used. Three reference genes (internal 
controls) were used for relative quantification. Normfinder 
[41] software was used to identify the optimal reference 
gene for internal normalization from a set of house-keeping 
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genes. Triplicates were averaged and data was normalized 
to the house keeping gene β-actin of day 0.
Statistical analysis
Statistical analysis was performed in SPSS 22 (SPSS Chi-
cago, IL). Differences between results were tested for sig-
nificance applying a post hoc Bonferroni test and a p value 
threshold of 0.05 for statistical significance; a p-value 
below 0.01 was considered highly significant.
Results
Figure 2 shows the high resolution and the excellent con-
trast of the morphological images acquired with the set-
ting described above. The scans show the changes of the 
lesioned area of the physis (marked by arrows) of one rep-
resentative animal for all 7 time points of the study and 
document the formation of bone bridges: On days 1 and 
3 after the drill procedure, the drill mark causing physeal 
interruption is clearly visible. On day 7 the physeal inter-
ruption caused by the drill mark disappears leaving a 
homogenous high signal physis. A first low-signal bone 
bridge can be seen as early as on day 14 and progressively 
becomes more defined as a larger low-signal interruption 
within a high signal physis. These interruptions did not 
dissolve until the end of the study. SNR values showed 
an observable decrease after two weeks: skeletal muscle 
exhibited an average SNR of 82 in the first 14 days and 76 
afterwards. For the physis, the SNR dropped from 72 to 36 
on average.
The analysis of the reference regions of all days and 
subjects yielded a relaxation rate of 0.82 ± 0.17 s−1. The 
results for the transfer coefficient and the extravascu-
lar extracellular volume provided by the reference region 
model are shown in Fig. 3: on day 1 post-operation K trans is 
at a minimum and ve is notably high; however, with strong 
variations. On day 3 a non-significant increase of the trans-
fer coefficient accompanied by a decrease in ve is evident. 
The value of K trans on day 7 is significantly increased com-
pared to day 1 and reaches its maximum on day 42 post-
operation (highly significant different from day 14) with 
a concomitant increase of the extravascular extracellular 
space. Between the results of days 7, 14 and 28 no statisti-
cally significant differences exist. The value for the transfer 
coefficient decreased significantly from day 42 to day 82 
accompanied by a decrease of ve. For the entire study the 
results for ve did not show significant differences between 
measurement days.
Concerning factors of vascular growth, a first visible 
but non-significant increase occurs on day 1 for VEGFa as 
an immediate reaction to the operation (Fig. 4). The only 
significant difference for VEGFa can be observed on day 7 
post-lesion which shows increased values compared to 
the baseline (day 0) and days 14 and 82. The expression 
of Hif1a increases from day 1 on with maximum values on 
day 3 yielding a highly significant increase compared to 
days 0, 14 and 82.
a b c d
e f g
Fig. 2  High resolution, non-contrast-enhanced MR Images of the 
lesioned area (arrow) in the tibial physis of one subject on days a 1, b 
3, c 7, d 14, e 28, f 42 and g 82 post-lesion (images were brightened 
for a better view of the anatomy). The formerly disrupted area looks 
closed on day 7 but on day 28 it is clearly disrupted again
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Finally, histological investigations additionally showed 
the development of microvasculature in the physeal defect. 
Figure 5 shows collagen IV-stained histologic slices of 
days 1, 3, 7, 14, 28, 42 and 82 of the physeal lesion. On 
day 1 the staining showed no vascularisation. On days 3 
and 7 post-operation the staining clearly displays the pres-
ence of capillaries (marked by arrowheads). After two 
weeks, first bony trabeculae (collagen IV-negative and 
marked by arrows) are observed within the physeal defect 
site. At this time-point collagen IV-positive vessels appear 
to be more structured compared to days 3 and 7. On day 42 
the defective area is filled with lamellar bone fragments, 
which are surrounded by vessels. On day 82 post-operation 
the number of collagen IV-positive vessels appear reduced 
compared to day 42.
Discussion
In order to detect bone bridge formation at an early stage 
using a minimally invasive method a reference region 
model was applied to DCE-MRI data of injured physes 
to analyze the changes of the microvessel system of this 
tissue. Furthermore, the changes of the pharmacokinetic 
parameter K trans over time were compared to qRT-PCR 
data and results of immunohistochemical analyses and the 
development of bone bridges was observed using high-res-
olution MRI.
The performed MRI studies show significant and clear 
time dependent changes of the assessed model parameter 
K
trans. This supports the hypothesis that changes of the 
blood supply are a potential mechanism associated with 
bone bridge formation of injured physes and permits a 
detection of the formation even before it becomes visible in 
MR imaging data.
Although this study was performed on a whole-body 
system, high quality morphological images could be 
obtained by using a dedicated receiver coil and by opti-
mizing the parameters of the 3D gradient echo sequence. 
The used setting provided images with a voxel size of 
0.19 mm × 0.19 mm × 0.72 mm, which allowed for an 
identification of the relevant image details. For the sec-
ond half of the study the image quality was noticeably 
decreased. This is owed to the growth of the animals caus-
ing an increase in the distance between the surface coils 
and the region of interest, which consequently lead to a 
Fig. 3  Results for a Ktrans and 
b ve (n = 5 for each day). Hori-
zontal bars indicate the median, 
the 25th and 75th percentiles. 
The values for the transfer 
coefficient start to increase after 
3 days and reach their maxi-
mum on day 42 post-operation. 
The volume of the extravascular 
extracellular space is increased 
on days 1 and 42 but does not 
show statistically significant 
changes. Statistical changes 
are marked with *p < 0.05 and 
































Fig. 4  Quantitative real time 
reverse transcription PCR 
results for a VEGFa and b 
Hif1a (n = 6 for each day). 
Horizontal bars indicate the 
median, the 25th and 75th 
percentiles, minor outliers are 
displayed with a circle; major 
outliers with a star. Maximum 
vascular growth occurs on day 7 
(VEGFa), forgone by maxi-
mum hypoxia on day 3 (Hif1a). 
Statistical changes are marked 
with *p < 0.05 and **p < 0.01, 
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decrease of the SNR of the acquired data. However, the 
sharp decrease for the SNR of the physis after 2 weeks is 
also caused by a diminished signal intensity of the region 
of interest due to the animals’ age. This is also reflected 
by the much less pronounced decrease in SNR for skeletal 
muscle. The images did not suffer from susceptibility arti-
facts; however, for higher field strengths this may be the 
case, as reported by Taha et al.  [42], who found a RARE 
approach to be superior to FLASH at 9.4 T.
The high quality of the morphological scans provided a 
good insight into physeal bone bridge formations through-
out the whole study. As was to be expected, the lesioned 
area can be clearly identified shortly after the application of 
the drilling procedure and the refillment of the injury was 
largely completed on day 7 post-operation. By only inves-
tigating image data for this day, this refillment could be 
accredited to healing processes closing the physeal lesion. 
While a remaining damage of the tibia was still visible, the 
formerly lesioned area of the physis was homogeneously 
closed and the isointensity of the filled lesion compared to 
the surrounding physis suggests a refillment with cartilagi-
nous tissue.
First changes in the investigated area become slightly 
visible in the MR images on day 14 but without additional 
information these changes cannot be positively assigned 
to a bone bridge formation. However, the discontinuity of 
the physeal area on day 28 is a strong indication for bony 
activity. This new interruption of the physis occurred in all 
examined subjects indicating a strong connection between 
injuries across the physis and bone bridge-induced defec-
tive healing, as suggested in the literature  [13, 15, 17, 34]. 
The onset of bone bridge formation is in good accordance 
with findings of a recent study investigating the efficacy 
of MRI for the detection of changes in bone morphology 
[42].
The specific requirements of this animal study lead to 
a moderate temporal resolution of the dynamic scan. This 
and the lack of a feeding artery in the investigated area 
required the application of an RRM to acquire pharmacoki-
netic parameters. The reference region was skeletal mus-
cle and the average relaxation rate of the reference regions 
of all days and subjects is in good agreement with litera-
ture values  [43, 44]. The analysis of the pharmacokinetic 
parameter K trans revealed changes in the investigated area, 
which were not visible in imaging data. These changes 
can be attributed to the underlying mechanisms of the for-
mation of bone bridges, which did not become visible in 
the morphological images before day 14 and could not be 
clearly identified before day 28 post-operation. On days 1 
and 3 post operation the lesion is mostly filled with blood, 
thus K trans cannot be reasonably determined. Especially on 
the first measurement day the development of blood vessels 
is expected to be still very low, which hinders a meaningful 
parameter identification. This, for instance, is reflected in 
the quite strong variance of the values for ve. However, 
from day 3 onwards the fitting routines provide robust, 
i.e. less scattering, results and the increase of K trans sug-
gests a proliferation of microvessels.
While it is not completely clear whether such an estab-
lishment of a microvessel structure triggers a defective 
healing and thereby hinders a restitutio ad integrum, it 
can be considered as a first sign for the formation of bone 
bridges. This is a remarkable finding, since prior to this 
study date neither histologic analysis nor MR image data 
could unambiguously detect newly formed bone tissue. 
Histology could confirm the presence of bone fragments 
in the lesioned area  [13] but it is still disputed if these 
bone fragments within a fracture site lead to the forma-
tion of bone bridges, as according to Xian et al.  [17], an 
irrigation of the drill track had no measurable effect on the 
development of osseous matter. Therefore, the determina-
tion of K trans allows for an earlier detection of bone bridge 
formation.
After day 3 post-operation the transfer coefficient indi-
cates a steady increase. The maximum value of K trans on 
day 42 reflects the blood supply of bone bridges, which 
could be clearly detected in the morphological images at 
that time.
The volume of the extravascular extracellular space did 
not provide additional information. The decrease at the 
beginning of the study could be interpreted as a sign for 
increased blood supply; however, it was reported that the 
RR estimate of ve and the estimate produced by the stand-
ard method with known AIF are not correlated  [45]. There-
fore, and since the changes of this parameter were only sta-
tistically non-significant the course of this quantity was not 
investigated further.
The analysis of collagen IV-stained histology data con-
firmed the presence of vascularity from day 3 onwards, 
which coincided with an increase of K trans. After two weeks 
the stained vessels appear less scattered but greater in size 
and first formations of bone bridges can be detected. This 
is followed by another increase of K trans until day 42 fol-
lowed by a decrease between days 42 and 82, which coin-
cides with a seemingly reduced staining. The voxel based 
integrative parameter Ktrans show a smoother development 
with less variation in comparison to parameter from histo-
logical samples.
The increased expression of VEGFa on day 7 is pre-
ceded by a rise in the expression of Hif1a with its maxi-
mum on day 3. VEGF expression has been reported to be 
induced by hypoxia [46]. Furthermore, the heterodimeric 
basic helix-loop-helix protein Hif1 has been attributed 
to directly activate VEGF transcription in hypoxic cells, 
implicating Hif1a to play a pivotal role within this cascade 
[47, 48]. Although, VEGF and Hif1a were not measured 
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on protein levels in our study, we suspect that, based on 
our qRT-PCR results, the changes of the microvessel sys-
tem and the increased values of K trans occurring on day 7 
were most probably triggered by hypoxia within the phy-
seal lesion site. The scattered VEGFa expression observed 
primarily on day 7 is presumably associated with the rela-
tive small sample size, where a short increase of expression 
towards the randomly selected day 7 may be hard to detect 
exactly. The statistical outlier of day 7, however, may be 
due to a contaminated sample by surrounding tissue.
Comparing the results of MR imaging and the phar-
macokinetic analyses to the complementary data it can be 
stated that the increase in K trans corresponds to a filling of 
the physeal injury with vasculature. The data also shows 
that the non-significant increase of K trans between days 7 
and 14 coincides with a return of VEGFa expression to 
its initial value on day 14. However, it is also notable that 
qRT-PCR results reveal a rather pronounced variance in the 
data while the pharmacokinetic analysis provides a clearly 
identifiable trend. The results suggest that the combination 
of high-resolution MRI with a pharmacokinetic analysis 
allows to identify bone bridge formation at an early stage, 
while being only minimally invasive.
Currently, Gadolinium-based contrast agents are not 
generally used for the detection of physeal bone bridges; 
however, contrast-enhanced measurements are already 
applied for different disorders, such as the Legg–Calvé–
Perthes disease [49]. Therefore, we expect our method to 
be generally applicable to children, which would provide 
a quantitative measure for changes in the micro-vessel 
system associated with the formation of bone bridges at 
an early stage. The detection of changes in Ktrans was at 
least 7 days earlier than the detection of first morphologi-
cal signs for bone bridges. This time period may translate 
from the specific animal model to a duration between 6 
and 19 months for humans [50, 51], which can be par-
ticularly important in cases with concealed physeal 
bridging. Clinically, many physeal bone bridges may not 
become evident until months or years have passed and 
growth disturbances have developed [1]. This highlights 
the necessity for early recognition of physeal bone bridge 
formation, which subsequently aids surgical management 
in order to restore potential growth to the bone.
Conclusion
In this study, we used DCE-MRI on a clinical system to 
assess parameters related to blood supply in an animal 
model in order to investigate the possibility to detect 
the formation of bone bridges using a minimally inva-
sive method. We conclude that a transphyseal lesion is 
associated with increased values for K trans which could 
be observed from day 3 onwards using DCE-MRI. The 
increase of the transfer coefficient coincides with a pres-
ence of vascularity, which appears to trigger the consecu-
tive bone bridge formation and thereby may hinder a res-
titutio ad integrum of the physeal defect.
MR measurements did not only document the forma-
tion of bone bridges but additionally provided quantita-
tive information on tissue development and microvessel 
proliferation in the lesioned area. The analysis of the 
DCE data enabled an indirect detection prior to visibil-
ity in morphology images, which may help in preventing 
growth disturbances in children by allowing therapeutic 
intervention early in course. This finding, however, still 
needs verification in a human study.
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